This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Emergent BioSolutions Inc
EBS : NYSE : Health Care
$22.81 -0.13 | -0.57%
Today's Range: 22.62 - 22.98
Avg. Daily Volume: 320,500
07/25/14 - 4:02 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
EBS EMERGENT BIOSOLUTIONS INC 22.22 831.27 43.57 323.53 17.78
IMGN IMMUNOGEN INC 10.79 925.93 n/m 57.98 67.31
EPZM EPIZYME INC 27.80 921.71 n/m 72.99 721.78
RCPT RECEPTOS INC 34.49 917.74 n/m 4.50 202.62
INSY INSYS THERAPEUTICS INC 25.26 864.62 18.44 129.87 429.87
SRPT SAREPTA THERAPEUTICS INC 20.67 840.81 n/m 15.83 -48.25
GHDX GENOMIC HEALTH INC 26.54 829.16 n/m 265.50 10.71
SGMO SANGAMO BIOSCIENCES INC 11.92 810.08 n/m 27.63 19.92
AEGR AEGERION PHARMACEUTICALS INC 27.43 808.72 n/m 74.29 5934.76
LXRX LEXICON PHARMACEUTICALS INC 1.42 731.22 n/m 2.14 86.16
ENTA ENANTA PHARMACEUTICALS INC 37.88 702.22 n/m 6.05 405.93
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

EBS Ind Avg S&P 500
43.57 52.05 19.42
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs